Related Experiment Videos
Role of rheologic factors in patients with acute central retinal vein occlusion
Insights
Elevated hematocrit and plasma viscosity are linked to central retinal vein occlusion (CRVO). These rheologic changes may play a role in CRVO development, regardless of other risk factors.
Area of Science:
- Ophthalmology
- Hematology
- Vascular Biology
Background:
- Central retinal vein occlusion (CRVO) is a significant cause of vision loss.
- Understanding the underlying rheologic factors in CRVO is crucial for diagnosis and treatment.
Purpose of the Study:
- To evaluate rheologic findings in acute CRVO.
- To correlate these findings with risk factors and clinical presentation (ischemic vs. nonischemic).
- To explore the etiology of rheologic changes in CRVO.
Main Methods:
- Prospective study of 173 patients with acute CRVO.
- Comparison with 173 matched control subjects.
- Measurement of hematocrit, plasma viscosity (PV), erythrocyte aggregation (SEA), and erythrocyte rigidity (SER).
Main Results:
- Significantly increased hematocrit and PV in CRVO patients (both ischemic and nonischemic) compared to controls.
- No significant differences in SEA or SER between CRVO groups or compared to controls.
- Elevated hematocrit and PV were independent of associated cardiovascular risk factors.
Conclusions:
- Increased hematocrit and plasma viscosity are potential contributing factors in the pathogenesis of CRVO.
- These rheologic alterations may be key elements in CRVO development.
Purpose:
To assess the rheologic findings in acute central retinal vein occlusion (CRVO) with respect to associated risk factors, the clinical appearance of ischemic or nonischemic CRVO, and to elucidate the etiology of possible changes.
Methods:
The authors enrolled 173 patients with acute CRVO (ischemic, 33%; nonischemic, 67%) in this prospective study. One hundred seventy-three patients who were matched for age, sex, and cardiovascular risk factors served as control subjects. All patients underwent testing to determine hematocrit values, plasma viscosity (PV), erythrocyte aggregation (SEA), and erythrocyte rigidity (SER).
Results:
Hemocrit values and PV were increased significantly (P<0.01) in patients with ischemic and nonischemic CRVO compared with control subjects but did not differ significantly between the two groups. No significant differences were found in SEA and SER values between the clinical subsets of patients with CRVO and when the patients were compared with matched control subjects. Analysis revealed that hemocrit and PV values were (P<0.001) increased significantly independent of associated cardiovascular risk factors.
Conclusion:
These results suggest that increased hemocrit and PV values may be contributing factors in the pathogenesis of CRVO.